Georgia Bids > Bid Detail

75A50322Q00019 SNS Pharmaceutical Buy

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Level of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Opps ID: NBD00159729068889323
Posted Date: Sep 5, 2022
Due Date: Sep 30, 2023
Solicitation No: 75A50322Q00019
Source: https://sam.gov/opp/ab4f6fe57e...
Follow
75A50322Q00019 SNS Pharmaceutical Buy
Active
Contract Opportunity
Notice ID
75A50322Q00019
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office
ASPR/ORM-SNS
General Information View Changes
  • Contract Opportunity Type: Solicitation (Updated)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Updated Published Date: Sep 05, 2022 06:45 am EDT
  • Original Published Date: Aug 09, 2022 04:22 pm EDT
  • Updated Date Offers Due: Sep 30, 2023 02:00 pm EDT
  • Original Date Offers Due: Aug 23, 2023 02:00 pm EDT
  • Inactive Policy: 15 days after date offers due
  • Updated Inactive Date: Oct 15, 2023
  • Original Inactive Date: Sep 07, 2023
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
    Atlanta , GA 30341
    USA
Description View Changes

Amendment 3 (see attached Q & A's and updated solicitation)



Amendment 2



SNS Pharmaceutical Buy (12 Months)



Amendment 0002 to Solicitation 75A50322Q00019



The purpose of this amendment is to extend the due date for receipt of proposals.



The hour and date specified for receipt to offers is hereby changed as follows: From 2:00 PM EST, 8/23/2022 TO: 12:00 PM EST, 9/23/2022.



The anticipated award date is hereby changed from September 30, 2022, to November 15, 2022.



Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods:



(a) By completing Items 8 and 15 and returning 1 copy of the amendment;



(b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or



(c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.



FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR.



If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.





AMENDMENT 1-



ADD Q & A FORM



Please submit questions on the attached Q & A Template (Attachment 3)





a. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice.



b. The solicitation number is 75A50322Q00019 and is being issued as a request for proposals.



c. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-06 dated 05-26-2022.



d. This acquisition is not a small business set-aside. The North American Industry Classification System (NAICS) code is 325412.



e. The Division of Strategic National Stockpile (DSNS), of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), intends to purchase bulk pharmaceuticals. The Government intends to evaluate offers and award a contract without discussions. However, the Government may, in its sole discretion, elect to conduct discussions if determined to be in the best interest of the Government.



f. Performance is anticipated to begin September 30, 2022. The period of performance is for a period of one year.



g. The provision at FAR 52.212-1, Instructions to Offerors-Commercial Items, applies to this acquisition. The Government intends, but is not obligated, to award multiple contracts. The Government anticipates awarding its entire 12-month pharmaceutical quantity for each pharmaceutical to a single offeror; however, an offeror may be awarded a contract for more than one Pharmaceutical. However, this does not obligate the Government to award a contract for each Pharmaceutical. The Government may accept any item, group of items, or quantity of an offer, unless the offeror qualifies the offer by specific limitations.



h. The provision 52.212-2, Evaluation-Commercial Items, applies to this procurement. Addenda to the provision include evaluation factors, subfactors and evaluation criteria.



i. Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. (Note, if offerors are registered within the System for Award Management (SAM) and certs and reps are up to date, make a statement to that effect in accordance with this clause).



Offers are due no later than August 23, 2022 on or before 2:00 PM Eastern Time by e-mail to the Subject Line RFP 75A50322Q00019 attention of Contracting Officer, Kimberly Golden at: OSContracting@cdc.gov. The offeror’s complete proposal (including all information required to be submitted as part of the offeror’s;



• Volume A - Completed 1449, & Fill-In Docs,



• Volume B -Technical Proposal,



• Volume C - Price/Business Proposal,



Offerors are directed to use the RFP attached to this amendment for their response to this solicitation. Offerors must confirm receipt of this amendment by completing sections 8,15A & 15B of the SF30 form and submit with the revised proposal.



Questions are due August 12, 2022, on or before 5:00 PM Eastern Time by e-mail: Subject Line QUESTIONS: RFP 75A50322Q00019 to the attention of Contracting Officer, Kimberly Golden at: OSContracting@cdc.gov.



The point of contact for information regarding this combined synopsis/solicitation is Kimberly Golden, OSContracting@cdc.gov.


Attachments/Links
Contact Information
Contracting Office Address
  • 2945 FLOWERS ROAD
  • Atlanta , GA 30341
  • USA
Primary Point of Contact
Secondary Point of Contact


History

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >